Bipha launches Ayush-64; An Ayurvedic drug for Asymptomatic, Mild to moderate COVID-19 Patients.
As we all know, the whole world is struggling with the second wave attack of Covid-19; the whole population going through the tough situation as it has affected a large population in our country. The vaccines are being produced and delivered but to make them available to a large number of the population takes a lot of effort and time. At this point, the Government has focused on integrated treatments for mild and moderate Covid-19 patients
AYUSH-64 has emerged as a ray of hope for the patients of mild and moderate COVID-19 infection; which is a polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS); which is in practice since 1980s for various conditions such as fever, inflammations and joint pains across CCRAS peripheral institutes.
Contains herbal extracts of Alstonia scholaris, Picrorhiza kurroa, Swertia chirata and Caesalpinia crista. The active ingredients showed notable antiviral, immunomodulatory, and antipyretic properties. The in-silico study done on AYUSH-64 showed that about 35 out of 36 of its Phyto-constituents have a high binding affinity against COVID 19 virus. It has been scientifically found to be useful in the treatment of asymptomatic, mild, and moderate COVID-19 infection and provide a relief from cough, cold and joint pain. And also significantly reduce the duration of clinical recovery in terms of disease symptoms and severity. It also has significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general wellbeing, and sleep.
Bipha is an innovative third-generation company: founded in 1929 by the renowned Ayurvedic Physician Koshy Varghese with nine decades of the presence of Ethical Products. Bipha is pioneer manufacturer of Patent Ayurvedic formulations in Kerala and had manufactured the first Ayurvedic Kashaya tablet formulations in India.
Today, Bipha has a global presence taking the name and fame of Ayurveda all over the world. While the world is rediscovering the goodness of Ayurveda, Bipha had developed many remedies for contemporary ailments to boost immunity against diseases. In the current scenario, Bipha founded with the mission of providing a good preventive measures; which boost your immunity & ensure your personal hygiene in order to control the spreading of disease .
Bipha has also procured the license for producing Ayush-64 which provide relief to mild and moderate Covid-19 affected patients. Completed its production and now onwards available at Bipha Healthcare store for distribution. Thus, providing vital help to Covid-19 treatment across our country. It’s our sincere belief that centuries old Ayurveda along with the commitment of the society and the environment will bring health and happiness to one and all.
AJAY GEORGE VARGHESE, MANAGING DIRECTOR